Paper Details

  1. Home
  2. Paper Details

Efficacy of pyridostigmine (Mestinon) in the relief of patients with epiphora.

Author: OklarMurat, YaziciogluTitap, İnanRahşan

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Epiphora is often attributed to dysfunction of the orbicularis oculi muscle, particularly the Horner muscle. This study investigates the effect of the anticholinergic drug pyridostigmine on patients with patent but dysfunctional lacrimal drainage systems.
Paper Details　
Original Abstract of the Article :
Although the mechanism is not clear, the inability of the orbicularis oculi muscle, especially the deeper segment (Horner muscle), is thought to be responsible in epiphora. This study evaluates the effect of the anticholinergic drug pyridostigmine (Mestinon) in patients with patent but dysfunctional...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.pdpdt.2022.103240

データ提供：米国国立医学図書館（NLM）

Pyridostigmine for the Relief of Epiphora

Epiphora, or excessive tearing, can be a real nuisance, like a persistent sandstorm in your desert. This study explores the potential of pyridostigmine, an anticholinergic drug, to alleviate epiphora by strengthening the orbicularis oculi muscle, which plays a role in tear drainage.

Investigating a New Treatment Approach for Epiphora

The study suggests that pyridostigmine might offer a novel therapeutic option for patients with epiphora, particularly those with a dysfunctional lacrimal drainage system.

Potential Benefits for Patients with Epiphora

If proven effective in larger studies, pyridostigmine could provide relief for individuals struggling with excessive tearing, improving their quality of life.

Dr. Camel's Conclusion

This study explores a potential new treatment approach for epiphora, offering hope for patients seeking relief from this persistent and often troublesome condition.

Date :
  1. Date Completed 2023-04-03
  2. Date Revised 2023-04-03
Further Info :

Pubmed ID

36592783

DOI: Digital Object Identifier

10.1016/j.pdpdt.2022.103240

Related Literature

Article Analysis
・Side Effects of pyridostigmine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.